Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Berger

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
Wiener Klinische Wochenschrift|September 20, 2002
[Vaccine protection in the elderly: are Austrian seniors adequately protected by vaccinations?]Ursula Hainz, Kurt Aigner, Esther Asch, et al.
JACC. Cardiovascular Interventions|September 26, 2009
Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (stenting of saphenous vein grafts) trialChristopher Lichtenwalter, James A de Lemos, Michele Roesle, et al.
JACC. Cardiovascular Interventions|February 26, 2011
Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trialEmmanouil S Brilakis, Christopher Lichtenwalter, Abdul-rahman R Abdel-karim, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 14, 2011
Paclitaxel-eluting stents reduce neointimal hyperplasia compared to bare metal stents in saphenous vein grafts: intravascular ultrasonography analysis of the SOS (Stenting of Saphenous Vein Grafts) trialOmar M Jeroudi, Abdul-Rahman R Abdel-Karim, Tesfaldet T Michael, et al.
International Journal of Cardiology|April 9, 2013
Prevalence and outcomes of intermediate saphenous vein graft lesions: findings from the stenting of saphenous vein grafts randomized-controlled trialAbdul-Rahman R Abdel-Karim, Monica Da Silva, Christopher Lichtenwalter, et al.
Aging Cell|January 22, 2010
miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human agingMatthias Hackl, Stefan Brunner, Klaus Fortschegger, et al.
Aging Cell|October 2, 2010
Identification of evolutionarily conserved genetic regulators of cellular agingGerhard T Laschober, Doris Ruli, Edith Hofer, et al.
Circulation|February 13, 2008
Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudyLeslee J Shaw, Daniel S Berman, David J Maron, et al.
Urologie (Heidelberg, Germany)|September 25, 2023
[Urinary incontinence after radical prostatectomy for prostate cancer-data from 17,149 patients from 125 certified centers]Christoph Kowalski, Nora Tabea Sibert, Peter Hammerer, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Wiener Klinische Wochenschrift|September 20, 2002
[Vaccine protection in the elderly: are Austrian seniors adequately protected by vaccinations?]Ursula Hainz, Kurt Aigner, Esther Asch, et al.
JACC. Cardiovascular Interventions|September 26, 2009
Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (stenting of saphenous vein grafts) trialChristopher Lichtenwalter, James A de Lemos, Michele Roesle, et al.
JACC. Cardiovascular Interventions|February 26, 2011
Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trialEmmanouil S Brilakis, Christopher Lichtenwalter, Abdul-rahman R Abdel-karim, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 14, 2011
Paclitaxel-eluting stents reduce neointimal hyperplasia compared to bare metal stents in saphenous vein grafts: intravascular ultrasonography analysis of the SOS (Stenting of Saphenous Vein Grafts) trialOmar M Jeroudi, Abdul-Rahman R Abdel-Karim, Tesfaldet T Michael, et al.
International Journal of Cardiology|April 9, 2013
Prevalence and outcomes of intermediate saphenous vein graft lesions: findings from the stenting of saphenous vein grafts randomized-controlled trialAbdul-Rahman R Abdel-Karim, Monica Da Silva, Christopher Lichtenwalter, et al.
Aging Cell|January 22, 2010
miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human agingMatthias Hackl, Stefan Brunner, Klaus Fortschegger, et al.
Aging Cell|October 2, 2010
Identification of evolutionarily conserved genetic regulators of cellular agingGerhard T Laschober, Doris Ruli, Edith Hofer, et al.
Circulation|February 13, 2008
Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudyLeslee J Shaw, Daniel S Berman, David J Maron, et al.
Urologie (Heidelberg, Germany)|September 25, 2023
[Urinary incontinence after radical prostatectomy for prostate cancer-data from 17,149 patients from 125 certified centers]Christoph Kowalski, Nora Tabea Sibert, Peter Hammerer, et al.
Pageof 11